Skip to content

Lidocaine spray reduce the pain of colposcopic cervical biopsy: a randomized controlled trial

Lidocaine spray reduce the pain of colposcopic cervical biopsy: a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20151118004
Enrollment
200
Registered
2015-11-18
Start date
2015-04-07
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

No more any harm to the patients. Because colposcopic directed biopsy have to do to every patients with abnormal Pap smear. Lidocain spray&#44

Interventions

10% lidocaine spray during colposcopic directed biopsy,Women were invited to participate which enrolled two groups of patients&#44
who received lidocaine spray and who did not received local anesthesia for their colposcopic biopsy procedures after Ethics committee approval and individual written informed consent were obtained. Th
Experimental Drug,Experimental Drug
Lidocaine spray reduce the pain of colposcopy directed biopsy:,No 10% lidocaine spray during colposcopic directed biopsy

Sponsors

no
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: abnormal cervical screening and colposcopic finding requiring a biopsy

Exclusion criteria

Exclusion criteria: know history of hypersensitivity to lidocaine or to other components of the solution, pregnancy, post hysterectomy, bleeding disorders, drug abuse, cervical and vaginal infection and inability to read or speak Thai.

Design outcomes

Primary

MeasureTime frame
effectiveness of lidocaine spray for pain relief during colposcopy directed biopsy 8 months a 10-cm numerical rating pain scale

Secondary

MeasureTime frame
no no no

Countries

Thailand

Contacts

Public ContactTanyalak Wongluecha

Chiang Mai University

Tanyalak_54@hotmail.com0854134454

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026